Fri Sep 10, 2010 14:00
Company Search
 Symbol Lookup
Quote Search
 Symbol Lookup
Featured Company
  IPOs
  Dividends Announced
  Economic Indicators
Company Main Page
WINTEAM PHARMA (570)
HSI: 21,159.30 -7.97
1.07
0.01 (0.9%)
As of12:30 10 Sep 2010
Open: 1.06 52Wk High: 1.29
Day High: 1.07 52Wk Low: 0.70
Day Low: 1.06 P/E: 37.943
Prev. Close: 1.06 Yield: 0.00%
Volume: 740K
Mkt Cap: 1.89B
Turnover: 788.3K NAV: 0.421
Quotes are delayed by at least 15 minutes.
Announcements
20 Aug 2010
Announcement: Change Of Company Logo
15 Aug 2010
Announcement: Announcement Of Interim Results For The Six Months Ended 30 June 2010
03 Aug 2010
Announcement: Date Of Board Meeting
12 Jul 2010
Announcement: Change Of Intermediate Controlling Shareholder
07 Jul 2010
Announcement: Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 June 2010
MORE >
Circulars
28 Apr 2010
Circular: Proposals For Re-Election Of Directors, General Mandates To Repurchase Its Own Shares And To Issue Shares And Notice Of Annual General Meeting
11 Mar 2010
Circular: (I) Major And Connected Transaction In Relation To Acquisition Of Equity Interest In Foshan City An Ning Company Limited; (Ii) Connected Transaction In Relation To Subscription Of New Shares By Connected Persons; And (Iii) Application For Whitew
03 Dec 2009
Circular: Continuing Connected Transactions
04 Aug 2009
Circular: (1) Proposal For Refreshment Of The Scheme Mandate Limit Of The Share Option Scheme; (2) Proposed Change Of Company Name; And (3) Proposed Re-Election Of Director
28 Apr 2009
Circular: Proposals For Re-Election Of Directors, General Mandates To Repurchase Its Own Shares And To Issue Shares And Notice Of Annual General Meeting
MORE >
Financial Reports

2010 Interim Report
2009 Annual Report

2009 Interim Report
2008 Annual Report
MORE >
Webcasts / Presentations / Interviews
Monthly Returns
03 Sep 2010
Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 August 2010
03 Aug 2010
Announcement: Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 July 2010
MORE >
Proxy Forms
28 Apr 2010
Form Of Proxy For Use At The Annual General Meeting Convened At 10:00 A.M. On Tuesday, 22 June 2010
11 Mar 2010
Form Of Proxy For Use At The Extraordinary General Meeting Convened At 10:00 A.M. On Monday, 29 March 2010
03 Dec 2009
Form of Proxy for use at the Extraordinary General Meeting convened at 10:00 a.m. on Monday, 21 December 2009
04 Aug 2009
Form of Proxy for use at the Extraordinary General Meeting convened at 10:00 a.m. on Friday, 28 August 2009
28 Apr 2009
Form of Proxy for use at the Annual General Meeting convened at 10:00 a.m. on Friday, 5 June 2009
MORE >
Company Profile

The principal activity of the Company is investment holding. The principal activities of the company’s subsidiaries are the production and sale of Chinese medicine and pharmaceutical products in the People’s Republic of China (“PRC”).

Financial Highlights
(HK$m)
2010
Interim
Turnover 437.80
Operating Profit 66.05
Pre-Tax Profit/Loss 64.45
Net Profit/Loss 29.05
Earnings Per Share(cents) 1.74
MORE >
Dividends
Year End Ex-Date (HK$)
Amount
2008Final 2009/5/27 0.007
2007Final 2008/5/16 0.005
Chairman
DURicheng Chairman
Financial Ratios
2010
Interim
Net Profit Margin 6.64
Gross Profit Margin 15.09
MORE >
Contact Info
Company Address:
 Rooms 2801-2805, China Insurance Group Building 141 Des Voeux Road Central, H.K.
Web: http://www.winteamgroup.com
Research Reports
MORE >
Disclaimer Statement: The above information is supplied by our data providers (SHK Financial Data and Infocast among others) and is for reference purposes only. Neither the Group nor any of its data providers is liable or responsible for the accuracy and reliability of the above information.The Group is not responsible for any loss or damage which may be incurred as a result of any decisions made in reliance on the information contained herein or caused by informational errors or delays.
Contact Quam IR
Tel: 2217-2912
 Email : quamir@quamgroup.com
Contact WINTEAM PHARMA

To request additional information on this company, please complete the form below and we will contact the company on your behalf.
Name:*
Company:
Position:
Phone:
E-mail:*
Existing Shareholder: Yes No
Message:*  

* Required Fields
News / Press Releases
16 Aug 2010
Winteam (00570) 1NP $29M, down 0.7%; no div
13 Jul 2010
Winteam's (00570) key shrhlder changes shrhlding interest
27 Apr 2010
WINTEAM PHARMA（570）bid for a Land in Foshan
27 Apr 2010
Winteam (00570) buys Foshan land for HQ, R&D centre
21 Apr 2010
Winteam (00570) '09 NP $44M, up 1.2X; no fin div
MORE >
Quam TV
HK Market Review 20100909
09 Sep 2010
Research Reports
MORE >
Click here for details of Insider Tradings
Event Calendar
Week Of05 Sep - 11 Sep2010
MORE MONTH>
Quam IR:
 Sitemap  |  About Us  |  Contact Us  |  Disclaimers     English | 繁體 | 简体   		Quam Group:
 Quam Limited  |  Quam Capital  |  Quam Securities
Quam Wealth  |  Quamnet 		A founding member of:
© 1998- Quamnet.com, Quam (HK) LImited and Quam (IA) Limited. All rights reserved. Quamnet.com, Quam (HK) Limited and Quam (IA) Limited endeavour to ensure the accuracy and reliability of the information but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or demage arising from any innaccuracies or omission
Information of Quam IR (Investor Relations):
 [Hong Kong Listed Company Information] [Financial News] [Announcement Alerts] [Free Delayed Stock Quote] [Chart]
[Hong Kong stock information]
QuamIR (Investor Relations) Services:
 [Listed Companies Information] [Listed Companies Financial Information] [Listed Companies Announcements]
[Listed Companies Circulars] [Listed Companies News] [Press Releases] [Listed Companies Event Calendar]
[Listed Companies Presentations] [Proxy Forms]
Quam IR (Investor Relations):
 [Securities Firms] [Fund Houses] [Venture Capitals] [Financial Public Relations Agencies] [Financial Printers]
Investor Relations Dictionary:
 [Listed Companies Result Announcement] [Financial Report] [Interim Report] [Annual General Meeting]
[Extraordinary General Meeting] [Board Meeting] [Annual Report] [Contact Listed Companies Investor Relations]
[Company Information Sheet] [Next Day Disclosure Return] [News Release] [IPO] [Prospectus] [Stock Quote] [Trading Volume]